Victoza May Cause Pancreatitis
Watchdog group the Public Citizen has concluded that the drug liraglutide (Victoza), which is used to treat type 2 diabetes, is linked to an increased risk of pancreatitis.
About the Public Citizen Study
According ot Medpage Today, researchers examined data from the Adverse Event Reporting System (AERS) between February 2010 and December 2011. They also cited several other studies that have found risks of pancreatitis with incretin drugs.
Out of 278 cases of acute pancreatitis that were reported within the first 2 years of Victoza being released on the market, 51 cases were “probably” caused by the drug. According to researchers, in 12 of those cases, the GLP-1 receptor agonist was the “highly probable” cause.
Soon after starting their drug therapy, researchers discovered that patients developed pancreatitis at a rate of 30% within 1 month and at 72% within 4 months.
60% of patients required hospitalization and two died from complications of acute pancreatitis. In most cases, the condition resolved when the medications were stopped.
Victoza is a once-daily injectable prescription medicine used to help improve blood sugar (glucose) in adults with type 2 diabetes. It is not used as a substitute for insulin or to treat type 1diabetes.
Other Victoza Side Effects of Victoza
The most common side effects associated with Victoza include:
- Increase in blood glucose
- Decreased weight
- Decreased appetite
- Pancreatic carcinoma